Health Care/Hospital

Nuance Pharma Closes Series D Financing

SHANGHAI, Dec. 8, 2020 /PRNewswire/ -- Nuance Pharma, a biopharmaceutical company engaged in creating value throughChina's specialty pharmaceutical markets with an established focus on iron deficiency, pain management and respiratory, today announced that it has successfully closed its Series D ...

2020-12-08 16:00 3980

Elekta reports major milestones achieved in MR-guided radiotherapy

STOCKHOLM, Dec. 8, 2020 /PRNewswire/ -- During the European Society for Radiotherapy and Oncology (ESTRO) and American Society for Radiation Oncology (ASTRO) Annual Meetings, users of the Elekta Unity MR-Linac presented 69 abstracts recounting the past years' worth of clinical experience with thi...

2020-12-08 15:30 2677

Over 65 speakers across 8 countries address critical themes of 'Readiness', 'Security' and 'Transparency' at URAP2 conference

Resilience for all from the next disaster - What should better preparedness mean after Covid-19, was discussed at two-day event, organised by UNSW,Sydney and SEEDS  SYDNEY, Dec. 8, 2020 /PRNewswire/ -- The vulnerable are most severely impacted as the frequency of naturally-triggered disasters is...

2020-12-08 15:22 1811

Novotech Health Holdings Announces Appointment of Anand Tharmaratnam as Chairman

SHANGHAI and SYDNEY, Dec. 8, 2020 /PRNewswire/ -- Novotech Health Holdings ("Novotech Holdings"), the largest biotech specialist contract research organization (CRO) inAsia, today announced the appointment of Anand Tharmaratnam as Chairman of the Board commencing1 April 2021. Dr Tharmaratnam br...

2020-12-08 13:00 1237

Syntellix Lauded by Frost & Sullivan for Breakthrough Technology in the Orthopedic and Trauma Market with its Bioresorbable Orthopedic Implant, MAGNEZIX

LONDON, Dec. 8, 2020 /PRNewswire/ -- Based on its recent analysis of the European orthopedic and trauma market, Frost & Sullivan recognizesSyntellix AG with the 2020 European Entrepreneurial Company of the Year Award. Its MAGNEZIX products are the world's first magnesium-based, metallically stabl...

2020-12-08 13:00 1060

Sam Ngoc Linh Kon Tum K5 has officially launched beauty and health products for men and women

KON TUM, Vietnam, Dec. 8, 2020 /PRNewswire/ -- The representatives of Sam Ngoc Linh Kon Tum K5 has just launched two beauty health products, including Love For Men's Health - a physiological enhancer for men's health; Love For Women's Health - supports the improvement of female hormones, premenop...

2020-12-08 13:00 1966

Cigna Global Employer Health Partners with InterNations to Offer a Scholastic Solution for Students, Chaperones and Faculty Participating in a Study Abroad Program

The new, flexible Cigna StudyWell™ offering makes it simple, predictable and affordable for populations studying abroad to access whole person health care.    BLOOMFIELD, Conn., Dec. 8, 2020 /PRNewswire/ -- Cigna Global Employer Health (CGEH) Americas, a division of global health service company...

2020-12-08 11:58 4464

Willis Towers Watson's Survey Expects Medical Costs in Indonesia to Increase up to 12% in 2021

JAKARTA, Indonesia, Dec. 8, 2020 /PRNewswire/ -- Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, announced it expects medical costs inIndonesia to increase up to 12%. Willis Towers Watson announced the findings following an in-depth report which cite...

2020-12-08 11:37 6497

China Renaissance Congratulates JD Health on its Landmark Hong Kong IPO

HONG KONG, Dec. 8, 2020 /PRNewswire/ -- China Renaissance ("China Renaissance", stock code: 1911.HK) congratulatesJD Health International Inc. ("JD Health" or the "Company", stock code: 6618.HK) on its landmark initial public offering ("IPO") on the Hong Kong Stock Exchange, which raised approxim...

2020-12-08 11:12 6277

TUV Rheinland certifies respirators

COLOGNE, Germany, Dec. 8, 2020 /PRNewswire/ -- TUV Rheinland InterCert is Notified Body for the certification of particle-filtering masks. Manufacturers can now have their products, also known as respirators, tested and certified in the laboratories of TUV Rheinland. For certification by the inte...

2020-12-08 09:41 1548

Ascentage Pharma Announces Positive Data from Pivotal Phase II Studies of HQP1351 (Olverembatinib) in Patients with TKI-Resistant Chronic Myeloid Leukemia (CML) at 2020 American Society of Hematology (ASH) Annual Meeting

SUZHOU, China, and ROCKVILLE, MD, Dec. 8, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today reported positive data from two pivotal...

2020-12-08 08:16 2119

Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

SAN FRANCISCO and SUZHOU, China, Dec. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...

2020-12-08 08:00 4352

A­­­­­izon Lauded by Frost & Sullivan for Its AI-powered Platform that Enables Pharma Companies to Achieve Smart and Continuous Manufacturing

Aizon accelerates pharma manufacturing by bolstering the client's currently deployed technology with AI and ML capabilities to boost production performance SANTA CLARA, Calif., Dec. 7, 2020 /PRNewswire/ -- Based on its recent analysis of the North American artificial intelligence (AI) market for ...

2020-12-08 01:57 1466

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

SAN FRANCISCO, Dec. 7, 2020 /PRNewswire/ -- PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery, today announced a strategic partnership with Pfizer Inc. (NYSE: PFE) with the goal of accelerating small molecule drug discovery by developing a ...

2020-12-07 22:37 3503

Through Strategic Collaboration with GenScript ProBio, Initium Therapeutics Plans to Utilize GenScript ProBio's Berkeley Lights Beacon Platform to Expand Their Antibody Drug Pipeline

NANJING, China, Dec. 7, 2020 /PRNewswire/ -- On December 7, 2020, GenScript ProBio and Initium Therapeutics announced that Initium Therapeutics has launched a single B-cell based antibody development platform through collaboration with GenScript ProBio. Initium Therapeutics is a US biotechnology ...

2020-12-07 22:00 1454

Happiness Biotech Provides Sales Update: E-Commerce Business of Over $3 million Since November

NANPING, China, Dec. 7, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that Happy Buy, the Company's wholly-owned subsidiary focusing on e-commerce business, has recorde...

2020-12-07 22:00 3741

Chaim Lotan, MD announces the official launch of DiNovA's Israel Incubator at ICI

TEL AVIV, Israel, Dec. 7, 2020 /PRNewswire/ -- December 7th, 2020, Chaim Lotan, MD announced the official launch of DiNovA Israel Incubator at the DiNovA Session of ICI (Innovations in Cardiovascular Interventions) 2020 Global Digital Summit. Earlier this year in April, Hangzhou Dinova Ruihua Me...

2020-12-07 21:50 2030

Global Cord Blood Corporation Announces Results of 2020 Annual General Meeting

HONG KONG, Dec. 7, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2020 Annual Ge...

2020-12-07 21:30 7900

PharmAbcine to present new interim data from its ongoing mTNBC trial at SABCS 2020

DAEJEON, South Korea, Dec. 7, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company will present the updated interim data from the ongoing phase Ib trial of olin...

2020-12-07 21:00 1094

Merck Expands Life Science Production Capacities in the United States

-- Expansions to significantly increase capacity by end of 2021 to meet unprecedented demand -- Combined expansion of Danvers, Massachusetts, and Jaffrey, New Hampshire, USA facilities to create nearly 700 new positions -- Business sector's announced 2020 investments total more than € 350 millio...

2020-12-07 21:00 2069
1 ... 587588589590591592593 ... 808